Gilead Sciences Inc
XHAM:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XHAM:GIS
|
US |
|
Dharma Satya Nusantara Tbk PT
IDX:DSNG
|
ID |
|
R
|
Rothwell International Co Ltd
KOSDAQ:900260
|
HK |
|
Loyaltypoint Inc
OTC:LYLP
|
US |
|
P
|
PTL Ltd
NASDAQ:PTLE
|
HK |
|
M
|
Morgan Stanley Direct Lending Fund
NYSE:MSDL
|
US |
|
Silitech Technology Corp
TWSE:3311
|
TW |
|
Grasim Industries Ltd
NSE:GRASIM
|
IN |
|
Angi Inc
NASDAQ:ANGI
|
US |
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
KR |
|
S
|
SV Investment Corp
KOSDAQ:289080
|
KR |
|
CNNC Hua Yuan Titanium Dioxide Co Ltd
SZSE:002145
|
CN |
|
K
|
Ko Ja Cayman Co Ltd
TWSE:5215
|
TW |
|
B
|
Bridger Aerospace Group Holdings Inc
NASDAQ:BAER
|
US |
|
T
|
Turnkey Communication Services PCL
SET:TKC
|
TH |
|
M
|
MR. D.I.Y. Holding (Thailand) PCL
SET:MRDIYT
|
TH |
|
City Holding Co
NASDAQ:CHCO
|
US |
Wall Street
Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for
GIS
is 134.47 EUR
with a low forecast of 100.78 EUR and a high forecast of 157.16 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GIS's stock price target?
Price Target
134.47
EUR
According to Wall Street analysts, the average 1-year price target for
GIS
is 134.47 EUR
with a low forecast of 100.78 EUR and a high forecast of 157.16 EUR.
What is Gilead Sciences Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Gilead Sciences Inc's revenue is
9%.
The projected
CAGR
for the next 3 years is
5%.
What is Gilead Sciences Inc's Operating Income forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Gilead Sciences Inc's operating income is
8%.
The projected
CAGR
for the next 3 years is
13%.
What is Gilead Sciences Inc's Net Income forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
Gilead Sciences Inc's net income is
8%.
The projected
CAGR
for the next 3 years is
16%.
